✦ LIBER ✦

P323 Second interim analysis of dose density with zoledronic acid treatment in metastatic breast cancer patients. ZARAS study

✍ Scribed by A. Rodríguez-Lescure; J. de la Haba; J. Baena; J. Martin; S. Morales; J. Chacon; J. Lopez; I. Fernandez; D. Aguiar; A. Garcia Palomo

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of second-line treatment

✍ Flemming Hansen; Peter Møller; Torben Skovsgaard 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 216 KB

NORDIC OBSERVATIONAL STUDY EVALUATING SA

✍ P-A. Abrahamsson; P. Ostri; M. Andersen; E. Kruger Hagen 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 72 KB

P319 Phase II study of high-dose toremif

✍ M. Sawaki; M. Wada; Y. Sato; Y. Mizuno; H. Kobayashi; K. Yokoi; M. Yoshihara; K. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 52 KB

PCN9 ATIME-IN-MOTION STUDY OF ORAL IBAND

✍ A Wardley; JJ Body; M Neary; G Lewis 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

24 Zoledronic acid (ZOL) as add-on thera

✍ G. von Minckwitz; M.D. Zahm; H. Eidtmann; H. Tesch; A. du Bois; K. Schwedler; J. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

360 Phase I/II study with paclitaxel in

✍ U. Klaassen; H. Wilke; D. Strumberg; C. Philippou Pari; A. Harstrick; W. Eberhar 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 158 KB